Suzhou Basecare Medical Corporation Limited (HKG:2170)

Hong Kong · Delayed Price · Currency is HKD

1.390

-0.030 (-2.11%)

Jun 18, 2026, 3:43 PM HKT

-53.97% (1Y)

Market Cap	380.20M -50.0%
Revenue (ttm)	259.59M -22.0%
Net Income	-248.66M
EPS	-0.91
Shares Out	273.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	217,000
Open	1.400
Previous Close	1.420
Day's Range	1.350 - 1.400
52-Week Range	1.320 - 4.360
Beta	0.04
Analysts	Strong Buy
Price Target	3.37 (+142.45%)
Earnings Date	Aug 28, 2026

About HKG:2170

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People’s Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kit to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage, implantation failures, and birth defects. It also provides DA500, a... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2010

Employees 407

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2170

Full Company Profile

Financial Performance

In 2025, HKG:2170's revenue was 233.27 million, a decrease of -22.01% compared to the previous year's 299.11 million. Losses were -223.46 million, -5.73% less than in 2024.

Financial numbers in CNY Financial Statements